FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to functional diagnostics, therapy, cardiology, gerontology, and can be used to determine biological age in males from 18 to 99 years old. An ultrasonic examination of the heart is performed and the following is determined: a ratio of the peak velocity of early-diastolic filling of the left ventricle to a peak velocity of late-diastolic filling of the left ventricle (E/A), index of end-systolic myocardial stress (ESMS), and by formula calculating biological age of male BA=0.32*CA-7.9*(E/A)+0.09*ESMS, where BA is biological age, years; CA – chronological age, years; E/A is a ratio of peak velocity of early-diastolic filling of left ventricle to peak velocity of late-diastolic filling of left ventricle; ESMS is a measure of end-systolic myocardial stress.
EFFECT: method enables increasing the objectivity of determining the biological age of males and the accuracy of stratifying the risk of cardiovascular complications.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING BIOLOGICAL AGE OF PEOPLE | 2005 |
|
RU2294692C1 |
METHOD FOR DETERMINING HUMAN BEING SENESCENCE RATE | 1999 |
|
RU2164381C2 |
METHOD FOR DETERMINING INDIVIDUAL'S BIOLOGICAL AGE | 2013 |
|
RU2518347C1 |
METHOD FOR DETERMINING HUMAN CARDIOVASCULAR SYSTEM AGING RATE | 1999 |
|
RU2193341C2 |
METHOD FOR PREDICTION OF RISK OF PREMATURE AGING OF YOUNG AND MIDDLE-AGED MEN | 2019 |
|
RU2722879C1 |
METHOD FOR OPTIMISATION OF MEN CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY IN CASE OF ANDROGENODEFICIENCY WITH ARTERIAL HYPERTENSION | 2016 |
|
RU2632449C1 |
METHOD OF DETERMINING PERSON'S BIOLOGICAL AGE AND RATE OF AGING | 2008 |
|
RU2387374C2 |
METHOD OF DETERMINING PERSON'S BIOLOGICAL AGE | 2012 |
|
RU2503404C1 |
METHOD OF ASSESSING AGE-RELATED CHANGES OF HUMAN CARDIOVASCULAR SYSTEM | 2012 |
|
RU2485886C1 |
METHOD FOR BIOLOGICAL AGE DETERMINATION FOR MEN | 2016 |
|
RU2617313C1 |
Authors
Dates
2020-07-06—Published
2019-10-31—Filed